203 results
8-K
EX-10.1
VXRT
Vaxart Inc
29 Feb 24
Departure of Directors or Certain Officers
4:30pm
Awards granted to Eligible Employees must be approved by either a majority of the Company’s “Independent Directors” (as such term is defined … ; and (F) the Fair Market Value applicable to a Stock Award; provided, however, that Stock Awards may only be granted by either (i) a majority
424B5
z7dgefqur0lmwht
17 Jan 24
Prospectus supplement for primary offering
7:18pm
8-K/A
80is30qkd6g7zfjmw4j4
23 Oct 23
Submission of Matters to a Vote of Security Holders
5:09pm
8-K
EX-3.1
nt88kanr evrd2qyn
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
5:01pm
8-K
bgkj7gta
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
5:01pm
8-K
EX-99.1
ze3aqfprnpal19tg8q
10 Jul 23
Vaxart Announces Positive Preliminary Topline Data from Dose-Ranging Phase 2 Study of its Bivalent Norovirus Vaccine Candidate
4:12pm
DEFA14A
gnfg46jj4ldhwonkwr
21 Jun 23
Additional proxy soliciting materials
5:18pm
424B5
orhc43jdi574l1gvo
8 Jun 23
Prospectus supplement for primary offering
4:17pm
424B5
pcift
6 Jun 23
Prospectus supplement for primary offering
5:21pm
424B5
qfezbbht6f b2mq
9 May 23
Prospectus supplement for primary offering
2:41pm
8-K
EX-99.1
th12v r0ptdt
1 Sep 22
Regulation FD Disclosure
7:05am